COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1916.1 | 1 | 0340-0650 | 88.89 | 650.61 | 376 | 73.01 | 0.886 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 397.0 | 1 | 0341-0649 | 316.53 | 648.68 | 283 | 62.77 | 0.903 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 501.5 | 1 | 0342-0650 | 522.00 | 651.01 | 317 | 68.43 | 0.851 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 510.0 | 1 | 0343-0651 | 570.73 | 650.76 | 211 | 55.11 | 0.873 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 340.5 | 1 | 0344-0651 | 800.58 | 651.10 | 287 | 63.11 | 0.905 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 349.3 | 1 | 0345-0648 | 909.49 | 648.45 | 257 | 60.53 | 0.882 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 392.0 | 1 | 0346-0654 | 254.61 | 654.82 | 304 | 67.36 | 0.842 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 517.2 | 1 | 0347-0653 | 445.55 | 652.66 | 256 | 59.94 | 0.895 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1218.2 | 1 | 0348-0654 | 367.50 | 653.95 | 286 | 62.77 | 0.912 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 410.7 | 1 | 0349-0656 | 762.40 | 655.48 | 294 | 64.18 | 0.897 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2297.3 | 1 | 0350-0664 | 667.52 | 664.31 | 302 | 63.94 | 0.928 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 3119.1 | 1 | 0351-0671 | 601.16 | 671.67 | 341 | 67.60 | 0.938 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2641.0 | 1 | 0352-0672 | 812.39 | 672.34 | 244 | 58.53 | 0.895 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 818.3 | 1 | 0353-0676 | 939.29 | 676.50 | 264 | 61.11 | 0.888 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 771.0 | 1 | 0354-0678 | 275.20 | 678.07 | 250 | 57.70 | 0.944 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 592.2 | 1 | 0355-0681 | 711.96 | 681.31 | 295 | 64.43 | 0.893 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1182.1 | 1 | 0356-0682 | 315.97 | 682.29 | 268 | 61.36 | 0.895 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 389.7 | 1 | 0357-0681 | 863.81 | 681.07 | 227 | 57.11 | 0.875 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1040.7 | 1 | 0358-0683 | 583.00 | 683.42 | 165 | 46.87 | 0.944 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 477.2 | 1 | 0359-0688 | 917.00 | 688.43 | 243 | 58.18 | 0.902 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 397.8 | 1 | 0360-0688 | 653.24 | 687.57 | 269 | 60.28 | 0.930 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 677.7 | 1 | 0361-0693 | 825.13 | 693.11 | 264 | 63.26 | 0.829 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 369.9 | 1 | 0362-0692 | 465.12 | 692.45 | 299 | 67.60 | 0.822 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 484.8 | 1 | 0363-0695 | 164.66 | 695.52 | 270 | 60.53 | 0.926 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 337.2 | 1 | 0364-0697 | 406.64 | 696.45 | 298 | 62.77 | 0.950 |